Definition/General
Introduction:
Carcinosarcoma of the breast is a rare type of metaplastic carcinoma, characterized by a mixture of malignant epithelial (carcinomatous) and malignant mesenchymal (sarcomatous) elements
It is a highly aggressive tumor with a poor prognosis.
Origin:
It is believed to arise from the metaplastic transformation of a single epithelial stem cell that differentiates along both epithelial and mesenchymal pathways
This is supported by the frequent finding of a gradual transition between the two components.
Classification:
It is classified as a subtype of metaplastic breast carcinoma
The sarcomatous component can be homologous (e.g., fibrosarcoma, osteosarcoma) or heterologous (e.g., rhabdomyosarcoma).
Epidemiology:
Carcinosarcoma is very rare, accounting for less than 0.1% of all breast cancers
It typically affects postmenopausal women.
Clinical Features
Presentation:
Presents as a large, rapidly growing, palpable breast mass
The mass is often firm and may be fixed to the skin or chest wall.
Symptoms:
A painless, large breast lump is the most common symptom
Skin changes like ulceration can occur.
Risk Factors:
The risk factors are not well-defined but are thought to be similar to other breast cancers
A history of radiation therapy may be a predisposing factor.
Screening:
Usually presents as a palpable mass
Mammographic and ultrasound findings are non-specific and can mimic other benign or malignant lesions.
Master Breast Carcinosarcoma Pathology with RxDx
Access 100+ pathology videos and expert guidance with the RxDx app
Gross Description
Appearance:
A large, well-circumscribed or infiltrative mass
The cut surface is often variegated, with fleshy, gray-white areas (sarcomatous) and firm, white areas (carcinomatous)
Areas of necrosis and hemorrhage are common.
Characteristics:
The tumor is typically large, often exceeding 5 cm
The consistency is variable, depending on the components.
Size Location:
Can occur anywhere in the breast.
Multifocality:
Rare.
Microscopic Description
Histological Features:
A biphasic tumor with an intimate mixture of malignant epithelial and mesenchymal components
The carcinomatous component is usually a high-grade ductal or squamous carcinoma
The sarcomatous component can be fibrosarcoma, osteosarcoma, chondrosarcoma, or other types.
Cellular Characteristics:
Both components show high-grade malignant features, including pleomorphism, hyperchromasia, and high mitotic activity.
Architectural Patterns:
The two components are typically intermingled
A transition zone between the carcinoma and sarcoma may be seen.
Grading Criteria:
These are considered high-grade tumors by definition.
Immunohistochemistry
Positive Markers:
The carcinomatous component is positive for cytokeratins (e.g., AE1/AE3)
The sarcomatous component is positive for mesenchymal markers like vimentin and other markers depending on the differentiation (e.g., desmin for rhabdomyosarcoma).
Negative Markers:
Both components are typically negative for hormone receptors (ER, PR) and HER2, making it a type of triple-negative breast cancer.
Diagnostic Utility:
IHC is essential to confirm the biphasic nature of the tumor and to differentiate it from other spindle cell lesions.
Molecular Subtypes:
Most are classified as triple-negative/basal-like breast cancer.
Molecular/Genetic
Genetic Mutations:
High frequency of TP53 mutations
Alterations in the PI3K/AKT/mTOR pathway are also common
Clonal analysis often shows a common origin for both components.
Molecular Markers:
Activation of the epithelial-mesenchymal transition (EMT) pathway is thought to play a key role.
Prognostic Significance:
Carcinosarcoma has a poor prognosis with a high rate of local and distant recurrence
Hematogenous spread is common.
Therapeutic Targets:
Treatment is primarily surgical
Due to its triple-negative status, it does not respond to hormonal or HER2-targeted therapy
Platinum-based chemotherapy is often used.
Differential Diagnosis
Similar Entities:
Malignant phyllodes tumor
Primary breast sarcoma
Metaplastic carcinoma with a single mesenchymal component.
Distinguishing Features:
Malignant phyllodes tumors have a benign epithelial component
Primary breast sarcomas lack an epithelial component
The distinction from other metaplastic carcinomas is based on the presence of both carcinomatous and sarcomatous malignant elements.
Diagnostic Challenges:
Distinguishing from other high-grade breast tumors on small biopsies can be difficult
A wide IHC panel is crucial.
Rare Variants:
The entire entity is a rare variant of metaplastic carcinoma.
Sample Pathology Report
Template Format
Sample Pathology Report
Complete Report: This is an example of how the final pathology report should be structured for this condition.
Specimen Information
[specimen type], measuring [size] cm in greatest dimension
Diagnosis
[diagnosis name]
Classification
Classification: [classification system] [grade/type]
Histological Features
Shows [architectural pattern] with [nuclear features] and [mitotic activity]
Size and Extent
Size: [X] cm, extent: [local/regional/metastatic]
Margins
Margins are [involved/uninvolved] with closest margin [X] mm
Lymphovascular Invasion
Lymphovascular invasion: [present/absent]
Lymph Node Status
Lymph nodes: [X] positive out of [X] examined
Special Studies
IHC: [marker]: [result]
Molecular: [test]: [result]
[other study]: [result]
Final Diagnosis
Final diagnosis: [complete diagnosis]